Final Report: Kenya Pharma.

Project Report | September 15, 2015

The Kenyan government committed to the goals of the Joint United Nations Program on HIV/AIDS. This means providing antiretroviral (ARV) drugs to 1.3 million people. To assist in this scale-up, The USAID-supported Kenya Pharma project created a safe, secure, and reliable national pharmaceutical supply chain.

To ensure that HIV/AIDS patients have consistent access to the drugs they need, the USAID-supported Kenya Pharma project created a secure and reliable supply chain that prevents stockouts, while expanding the number of service delivery points (SDPs) where patients can receive antiretroviral (ARV) drugs. To expand access, Kenya Pharma expanded care through satellite facilities in remote areas, and in partnership with the Kenyan government, upgraded facilities to enhance access to treatment. The project and the Kenyan government collaborated on all of these interventions to ensure continuity after the project ends.